165 related articles for article (PubMed ID: 18429232)
1. Serpins (serine protease inhibitors).
Bauman SJ; Whinna HC; Church FC
Curr Protoc Protein Sci; 2002 Feb; Chapter 21():21.7.1-21.7.14. PubMed ID: 18429232
[TBL] [Abstract][Full Text] [Related]
2. The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions.
Chan ED; King PT; Bai X; Schoffstall AM; Sandhaus RA; Buckle AM
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339082
[TBL] [Abstract][Full Text] [Related]
3. ANISERP: a new serpin from the parasite Anisakis simplex.
Valdivieso E; Perteguer MJ; Hurtado C; Campioli P; Rodríguez E; Saborido A; Martínez-Sernández V; Gómez-Puertas P; Ubeira FM; Gárate T
Parasit Vectors; 2015 Jul; 8():399. PubMed ID: 26215984
[TBL] [Abstract][Full Text] [Related]
4. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
Stone SR; Le Bonniec BF
J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
[TBL] [Abstract][Full Text] [Related]
6. Serpin-glycosaminoglycan interactions.
Rein CM; Desai UR; Church FC
Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
[TBL] [Abstract][Full Text] [Related]
7. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
[TBL] [Abstract][Full Text] [Related]
8. Heparin enhances serpin inhibition of the cysteine protease cathepsin L.
Higgins WJ; Fox DM; Kowalski PS; Nielsen JE; Worrall DM
J Biol Chem; 2010 Feb; 285(6):3722-3729. PubMed ID: 19959474
[TBL] [Abstract][Full Text] [Related]
9. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.
Pike RN; Buckle AM; le Bonniec BF; Church FC
FEBS J; 2005 Oct; 272(19):4842-51. PubMed ID: 16176258
[TBL] [Abstract][Full Text] [Related]
10. Identification of thrombin residues that modulate its interactions with antithrombin III and alpha 1-antitrypsin.
Le Bonniec BF; Guinto ER; Stone SR
Biochemistry; 1995 Sep; 34(38):12241-8. PubMed ID: 7547966
[TBL] [Abstract][Full Text] [Related]
11. Plants and the study of serpin biology.
Roberts TH; Ahn JW; Lampl N; Fluhr R
Methods Enzymol; 2011; 499():347-66. PubMed ID: 21683262
[TBL] [Abstract][Full Text] [Related]
12. Serpin receptor 1: a hepatic receptor that mediates the clearance of antithrombin III-proteinase complexes.
Pizzo SV
Am J Med; 1989 Sep; 87(3B):10S-14S. PubMed ID: 2552799
[TBL] [Abstract][Full Text] [Related]
13. Serpins in thrombosis, hemostasis and fibrinolysis.
Rau JC; Beaulieu LM; Huntington JA; Church FC
J Thromb Haemost; 2007 Jul; 5 Suppl 1(Suppl 1):102-15. PubMed ID: 17635716
[TBL] [Abstract][Full Text] [Related]
14. Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases.
Mkaouar H; Akermi N; Mariaule V; Boudebbouze S; Gaci N; Szukala F; Pons N; Marquez J; Gargouri A; Maguin E; Rhimi M
Microb Cell Fact; 2016 Nov; 15(1):201. PubMed ID: 27894344
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
16. Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes.
Olson ST; Bock PE; Kvassman J; Shore JD; Lawrence DA; Ginsburg D; Björk I
J Biol Chem; 1995 Dec; 270(50):30007-17. PubMed ID: 8530403
[TBL] [Abstract][Full Text] [Related]
17. Interaction of activated protein C with serpins.
Hermans JM; Stone SR
Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):239-45. PubMed ID: 8216224
[TBL] [Abstract][Full Text] [Related]
18. [Anticoagulative and anticomplementary activity of endogenous inhibitor preparation from hepatopancreas of red king crab (Paralithosed camtschaticus) towards human blood].
Balashova MV; Liutova LV; Rudenskaia IuA; Isaev VA; Andina SS; Kozlov LV; Rudenskaia GN
Biomed Khim; 2012; 58(2):176-88. PubMed ID: 22724357
[TBL] [Abstract][Full Text] [Related]
19. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
Mast AE; Enghild JJ; Pizzo SV; Salvesen G
Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
